Latest Articles
Amy Schumer says she lost 50lbs to 'survive' potentially fatal disease - LADbible
Amy Schumer says she lost 50lbs to 'survive' potentially fatal disease LADbible
Published: Dec. 2, 2025, 12:46 p.m.
Bayer aims Mirena at women's health issue with no treatment - pharmaphorum
Bayer aims Mirena at women's health issue with no treatment pharmaphorum
Published: Dec. 2, 2025, 12:25 p.m.
Ziwig Publishes Validation Study for Saliva-Based Endometriosis Test - Femtech Insider
Ziwig Publishes Validation Study for Saliva-Based Endometriosis Test Femtech Insider
Published: Dec. 2, 2025, 11:38 a.m.
Fun-filled fashion show helped raise hundreds of pounds for West Lothian charity - Daily Record
Fun-filled fashion show helped raise hundreds of pounds for West Lothian charity Daily Record
Published: Dec. 2, 2025, 11:22 a.m.
Round up: First wearable detects symptoms of perimenopause, and more - FemTech World
Round up: First wearable detects symptoms of perimenopause, and more FemTech World
Published: Dec. 2, 2025, 11:04 a.m.
As women with ‘invisible illnesses’ struggle to be believed, a report on chronic pain could help - CBC
As women with ‘invisible illnesses’ struggle to be believed, a report on chronic pain could help CBC
Published: Dec. 2, 2025, 11 a.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - PR Newswire UK
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence PR Newswire UK
Published: Dec. 2, 2025, 9 a.m.
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia - Bayer
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia Bayer
Published: Dec. 2, 2025, 7:30 a.m.
Link copied to clipboard!